Literature DB >> 9668068

Circulation of cholesterol between lysosomes and the plasma membrane.

Y Lange1, J Ye, T L Steck.   

Abstract

The cholesterol in the lysosomes of cultured human fibroblasts was determined to constitute approximately 6% of the cell total. This pool was enlarged by as much as 10-fold in Niemann-Pick type C cells. Certain amphiphiles (e.g. U18666A, progesterone, and imipramine) caused lysosomal cholesterol to increase to similarly high levels at a rate of approximately 0.8% of cell cholesterol/h. Lysosomal cholesterol accumulated even in the absence of exogenous lipoproteins. Furthermore, nearly all of the lysosomal cholesterol in both of the two perturbed systems was shown to be derived from the plasma membrane. Oxysterols known to alter cholesterol movement and homeostasis blocked lysosomal cholesterol accretion in amphiphile-treated cells, suggesting that this process is regulated physiologically. Treating cells with amphiphiles slightly reduced the efflux of cholesterol from lysosomes and slightly increased the influx from the plasma membrane, causing the lysosomal cholesterol compartment to double in size in approximately 15 h. After more prolonged amphiphile treatments, a population of buoyant lysosomes appeared that exchanged cholesterol with the plasma membrane completely but slowly. Niemann-Pick type C lysosomes were similarly buoyant and sluggish. We conclude that cholesterol circulates bidirectionally between the plasma membrane and lysosomes. The massive accumulation of lysosomal cholesterol in the perturbed cells does not appear to reflect disabled lysosomal transport but rather the formation of lysosomes modified for lipid storage, i.e. lamellar bodies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668068     DOI: 10.1074/jbc.273.30.18915

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  β-sitosterol inhibits high cholesterol-induced platelet β-amyloid release.

Authors:  Chun Shi; Jun Liu; Fengming Wu; Xiaoming Zhu; David T Yew; Jie Xu
Journal:  J Bioenerg Biomembr       Date:  2011-10-04       Impact factor: 2.945

2.  Nonesterified cholesterol content of lysosomes modulates susceptibility to oxidant-induced permeabilization.

Authors:  John J Reiners; Miriam Kleinman; David Kessel; Patricia A Mathieu; Joseph A Caruso
Journal:  Free Radic Biol Med       Date:  2010-11-11       Impact factor: 7.376

3.  Attenuation of the lysosomal death pathway by lysosomal cholesterol accumulation.

Authors:  Hanna Appelqvist; Cathrine Nilsson; Brett Garner; Andrew J Brown; Katarina Kågedal; Karin Ollinger
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Origins of intestinal ABCA1-mediated HDL-cholesterol.

Authors:  F Jeffrey Field; Kim Watt; Satya N Mathur
Journal:  J Lipid Res       Date:  2008-08-18       Impact factor: 5.922

5.  Use of mutant 125I-perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells.

Authors:  Akash Das; Joseph L Goldstein; Donald D Anderson; Michael S Brown; Arun Radhakrishnan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

6.  Antipsychotic-induced increase in lipid biosynthesis: activation through inhibition?

Authors:  Silje Skrede; Vidar Martin Steen; Johan Fernø
Journal:  J Lipid Res       Date:  2012-12-07       Impact factor: 5.922

7.  Late endosome motility depends on lipids via the small GTPase Rab7.

Authors:  Cécile Lebrand; Michela Corti; Holly Goodson; Pierre Cosson; Valeria Cavalli; Nathalie Mayran; Julien Fauré; Jean Gruenberg
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

Review 8.  Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Authors:  Richard J Cenedella
Journal:  Lipids       Date:  2009-05-14       Impact factor: 1.880

9.  Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.

Authors:  José M Jiménez-López; Pablo Ríos-Marco; Carmen Marco; Josefa L Segovia; María P Carrasco
Journal:  Lipids Health Dis       Date:  2010-03-25       Impact factor: 3.876

10.  Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.

Authors:  Rolando E Yanes; Derrick Tarn; Angela A Hwang; Daniel P Ferris; Sean P Sherman; Courtney R Thomas; Jie Lu; April D Pyle; Jeffrey I Zink; Fuyuhiko Tamanoi
Journal:  Small       Date:  2012-11-14       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.